Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 24.20
-0.54 (-2.18%)
At close: May 12, 2026
SHA:688739 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 57.66 | 131.79 | 342.82 | 465.92 | 714.02 | 892.49 |
Depreciation & Amortization | 175.01 | 175.01 | 172.18 | 125.27 | 121.22 | 116.1 |
Other Amortization | 7.65 | 7.65 | 3.81 | 3.71 | 2.22 | 1.32 |
Loss (Gain) From Sale of Assets | 0 | 0 | -0.09 | -2.48 | -0.04 | -0.01 |
Asset Writedown & Restructuring Costs | 81.17 | 81.17 | 1.8 | 0.87 | 0.83 | 0.71 |
Loss (Gain) From Sale of Investments | -67.36 | -67.36 | 60.02 | 20.27 | -27.25 | -14.2 |
Provision & Write-off of Bad Debts | 8.44 | 8.44 | 8.66 | 12.77 | 15.08 | 16.44 |
Other Operating Activities | 94.88 | 39.6 | 33.21 | 55.43 | 7.98 | 8.11 |
Change in Accounts Receivable | 18.39 | 18.39 | -18.02 | 13.82 | -156.41 | -436.49 |
Change in Inventory | -52.76 | -52.76 | -73.27 | 0.42 | -104.11 | -109.74 |
Change in Accounts Payable | -2.71 | -2.71 | -27.59 | -11.84 | -17.55 | 45.15 |
Change in Other Net Operating Assets | 0.13 | 0.13 | 0.06 | 0.06 | 0.08 | 0.1 |
Operating Cash Flow | 322.02 | 340.86 | 500.96 | 677.01 | 546.49 | 506.38 |
Operating Cash Flow Growth | -36.39% | -31.96% | -26.00% | 23.88% | 7.92% | -41.09% |
Capital Expenditures | -279.57 | -308.08 | -362.48 | -551.99 | -511.61 | -508.35 |
Sale of Property, Plant & Equipment | 0 | 0 | 10.98 | 0.02 | 0.15 | 0.02 |
Cash Acquisitions | -0.13 | -0.13 | -0.06 | -0.06 | -0.08 | -0.09 |
Investment in Securities | 4.4 | 154.4 | 156.81 | -883.2 | 3,327 | -2,598 |
Other Investing Activities | 31.05 | 26.94 | 31.92 | 32.95 | 75.04 | 40.72 |
Investing Cash Flow | -244.25 | -126.88 | -162.83 | -1,402 | 2,890 | -3,066 |
Long-Term Debt Repaid | - | -6.51 | -5.85 | -6.38 | -5.41 | -5.63 |
Net Debt Issued (Repaid) | -6.51 | -6.51 | -5.85 | -6.38 | -5.41 | -5.63 |
Issuance of Common Stock | - | - | - | - | - | 4,371 |
Repurchase of Common Stock | -10.79 | -10.79 | -50 | -99.99 | - | - |
Common Dividends Paid | -329.26 | -329.23 | -329.38 | -416.32 | -416.3 | - |
Dividends Paid | -329.26 | -329.23 | -329.38 | -416.32 | -416.3 | - |
Other Financing Activities | 0.61 | - | - | - | - | -18.95 |
Financing Cash Flow | -345.95 | -346.53 | -385.23 | -522.69 | -421.7 | 4,347 |
Foreign Exchange Rate Adjustments | -0.7 | 0.69 | 0.55 | 2.29 | 1.58 | -0.36 |
Net Cash Flow | -268.89 | -131.86 | -46.55 | -1,246 | 3,017 | 1,787 |
Free Cash Flow | 42.45 | 32.78 | 138.48 | 125.02 | 34.89 | -1.97 |
Free Cash Flow Growth | -73.51% | -76.33% | 10.76% | 258.36% | - | - |
Free Cash Flow Margin | 3.25% | 2.36% | 8.26% | 7.14% | 1.92% | -0.09% |
Free Cash Flow Per Share | 0.10 | 0.08 | 0.34 | 0.30 | 0.08 | -0.01 |
Cash Income Tax Paid | 94.29 | 94.29 | 177.45 | 182.09 | 211.18 | 198.48 |
Levered Free Cash Flow | -181.75 | -170.68 | 52.13 | 46.39 | -182.35 | -228.08 |
Unlevered Free Cash Flow | -180.89 | -169.79 | 53.11 | 47.28 | -181.53 | -227.12 |
Change in Working Capital | -35.44 | -35.44 | -121.46 | -4.75 | -287.57 | -514.57 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.